They should have been banned:
It was “a success for the entire advertising community,” Dan Jaffe, executive vp of the Association of National Advertisers, a trade group, tells the paper. Lobbying groups including the National Association of Broadcasters and the Advertising Coalition, which rep a variety of media interests and advertisers, swung into action. To them, the idea that regulators would be able to block ads about a new drug was a business disaster in the making.
